Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List

$26.41 0.00 (0.00%)

As of 07/2/2026 04:10 PM Eastern

What stocks does THNR hold?

The Amplify Weight Loss Drug & Treatment ETF (THNR) top stock holdings include Novo Nordisk A/S, Eli Lilly and Company, and Scholar Rock. The top 23 THNR holdings ordered by weight make up 100.00% of the total fund. THNR is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes a complete THNR stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 23 THNR Holdings

Rank	Company	Current Price	Weight	Shares Held
1	NVO Novo Nordisk A/S	$50.39 -0.1%	9.91%	8,881
2	LLY Eli Lilly and Company	$1,208.37 -0.5%	9.45%	337
3	SRRK Scholar Rock	$54.88	5.76%	4,531
4	HIMS Hims & Hers Health	$36.75 -0.1%	5.53%	7,013
5	VKTX Viking Therapeutics	$37.44	5.43%	6,142
6	ABBV AbbVie	$260.88 -0.1%	5.30%	901
7	REGN Regeneron Pharmaceuticals	$654.27	5.01%	341
8	MRK Merck & Co., Inc.	$129.34 -0.2%	5.01%	1,677
9	AstraZeneca PLC	N/A	5.00%	1,143
10	ARWR Arrowhead Pharmaceuticals	$83.99	4.99%	2,722
11	Roche Holding AG	N/A	4.95%	513
12	AMGN Amgen	$374.15	4.90%	589
13	Innovent Biologics, Inc.	N/A	4.78%	21,500
14	Chugai Pharmaceutical Co., Ltd.	N/A	4.59%	4,300
15	PFE Pfizer	$24.29 -0.1%	4.49%	7,957
16	CSPC Pharmaceutical Group Limited	N/A	4.36%	220,000
17	Zealand Pharma A/S	N/A	3.46%	3,434
18	KLRA Kailera Therapeutics	$21.99	2.35%	4,864
19	Jiangsu Hengrui Pharmaceuticals Co.,Ltd	N/A	2.10%	13,400
20	Hanmi Pharm. Co., Ltd.	N/A	1.89%	341
21	Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional Class	N/A	0.54%	23,072
22	OTHER ASSETS AND LIABILITIES	N/A	0.20%	160,588,413
23	JAPANESE YEN	N/A	0.00%	2,993

THNR Geographic Exposure

THNR's largest geographic exposure is United States at 68.0%, followed by Cayman Islands at 5.2%.

United States
68.0%
Cayman Islands
5.2%
United Kingdom
5.0%
Hong Kong
4.7%
Japan
4.4%
Denmark
3.6%
Korea, Republic of
2.1%

THNR Currency Exposure

THNR's largest currency exposure is USD at 77.7%, followed by HKD at 12.2%.

USD
77.7%
HKD
12.2%
JPY
4.4%
DKK
3.6%
KRW
2.1%

THNR Sector Exposure

THNR's largest sector exposure is Health Care at 89.8%.

Health Care
89.8%

THNR Industry Exposure

THNR's largest industry exposure is Biotechnology at 84.0%, followed by Health Care Providers & Services at 5.7%.

Biotechnology
84.0%
Health Care Providers & Services
5.7%

THNR Sub-Industry Exposure

THNR's largest sub-industry exposure is Biotechnology at 84.0%, followed by Health Care Services at 5.7%.

Biotechnology
84.0%
Health Care Services
5.7%

Related Companies and Tools

Related Companies

This page (NYSEARCA:THNR) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List